X2S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 1.7735 EUR Market Closed

Market Cap: €2.4B

S	Sinopharm Group Co Ltd XMUN:X2S	CN
	Aviva PLC F:GU81	UK
N	Nice Ltd TASE:NICE	IL
A	Ananda Development PCL SET:ANAN	TH
S	Spero Therapeutics Inc F:2HA	US
T	Tegna Inc F:GTT	US
F	First Majestic Silver Corp XMUN:FMV	CA

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

9% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

3% > 3%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.